Acquired Resistance to Targeted Therapies against Oncogene-Driven Non-Small Cell Lung Cancer: Approach to Subtyping Progressive Disease and Clinical Implications

In the emerging era of targeted therapy for advanced stage non-small cell lung cancer (NSCLC), it is becoming increasingly important to anticipate potential underlying driver oncogene alterations at the time of initial diagnosis and tumor tissue acquisition, so that patients can be selected in a tim...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Lung Cancer
Egile Nagusiak: Gandara, D.R., Li, T., Lara, P.N., Kelly, K., Riess, J.W., Redman, M. W., Mack, P.C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4586161/
https://ncbi.nlm.nih.gov/pubmed/24176733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2013.10.001
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak